This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Aclasta 5mg/100 ml Solution for infusion EU/1/05/308/001 Sandoz Pharmaceuticals d.d | Zoledronic acid |
| Carboplatin-Teva 10 mg/ml Concentrate for Solution for Infusion (50mg/5ml presentation) PA0749/004/001 Teva Pharma B.V. | Carboplatin |
| Cisplatin 1 mg/ml Concentrate for Solution for Infusion PA0822/199/001 Pfizer Healthcare Ireland | Cisplatin |
| Creon 10000 Gastro Resistant Capsules PA23355/006/001 Viatris Healthcare Limited | Lipase & Amylase & Protease |
| Creon 25000 Gastro Resistant Capsules PA23355/006/002 Viatris Healthcare Limited | Lipase & Amylase & Protease |
| Deslor 0.5 mg/ml Oral Solution PA0711/202/002 Rowex Ltd | Desloratadine |
| Dexamethasone Phosphate 4 mg/ml Solution for Injection PA0822/201/001 Pfizer Healthcare Ireland | Dexamethasone |
| Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops, solution PA23259/011/001 Bausch + Lomb Ireland Limited | Cyclopentolate |
| NovoSeven (250 KIU) EU/1/96/006/006 Novo Nordisk A/S | Eptacog alfa (activated) |
| Telmisartan Rowa 40mg Tablets PA0074/078/002 Rowa Pharmaceuticals Limited | Telmisartan |
| Temgesic 200 microgram Sublingual Tablets PA23460/001/001 Eumedica Pharmaceuticals GmbH | Buprenorphine |
| Tyvense 40mg Capsules PA23211/005/003 Takeda Pharmaceuticals International AG Ireland Branch | Lisdexamfetamine |
| Zofran 4mg/2ml Solution for Injection or Infusion PA0711/327/001 Rowex Ltd | Ondansetron |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Amorolfine 5 % w/v medicated nail lacquer PA0711/309/001 Rowex Ltd | Amorolfine |
| Anapen 500 micrograms / 0.3ml solution for injection in a pre-filled syringe PA22580/001/003 Bioprojet Pharma | Epinephrine |
| Canesten 500 mg Pessary PA1410/039/009 Bayer Limited | Clotrimazole |
| Evorel 50 micrograms per 24 hours Transdermal Patch PA22668/008/001 Theramex Ireland Limited | Estradiol |
| GlucaGen HypoKit 1 mg powder and solvent for solution for injection PA0218/031/002 Novo Nordisk A/S | Glucagon |
| Leucovorin-Teva 10mg/ml Concentrate for Solution for Infusion PA0749/001/001 Teva Pharma B.V. | Folinic acid |
| Nordurine 0.1 mg Tablets PA1009/017/001 Ferring Ireland Ltd | Desmopressin |
| Quetex XR 300 mg prolonged-release tablets PA0711/258/003 Rowex Ltd | Quetiapine |
| Skinoren 15% Gel PA1025/009/001 LEO Pharma A/S | Azelaic acid |
| Subutex 2 mg sublingual tablets PA22617/001/002 Indivior Europe Limited | Buprenorphine |
| Travocort® 0.1 + 1% w/w Cream PA1025/012/001 LEO Pharma A/S | Diflucortol & Isoconazole |
| Trinomia 100 mg/40 mg/5 mg hard capsules PA1744/002/005 Ferrer Internacional, S.A | Acetylsalicylic acid & Ramipril & Atorvastatin |
| Vokanamet 50 mg/1000 mg film-coated tablets EU/1/14/918/004-006 Janssen-Cilag International NV | Metformin & Canagliflozin |
| Zithromax Powder for Oral Suspension 200mg/5ml PA0822/191/002 Pfizer Healthcare Ireland | Azithromycin |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.